Schedule 13G ownership disclosure
SCPHARMACEUTICALS INC
Common Stock, par value $0.0001 per share · CUSIP: 810648105
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Weiss Asset Management LP
Shares: 2,881,669.00 · Class: 5.4%
- WAM GP LLC
Shares: 2,881,669.00 · Class: 5.4%
- WEISS ANDREW M
Shares: 2,881,669.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001357550-25-000034
- Form type
- SCHEDULE 13G
- Filer
- Weiss Asset Management LP
- CIK
- CIK 1357550
- Filed
- Nov 12, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership